The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Pfizer Inc. is offering about 662 million shares in Haleon Plc, representing its remaining stake in the maker of Sensodyne ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is ...

Pfizer constantly optimizes our manufacturing network, which can include transferring products into sites with available capacity." Pfizer no longer has any adeno-associated virus gene therapies ...

Since that time, though, demand for these products has declined, and that's resulted in lower revenue and a drop in the Pfizer share price. Right now, as an investor, you may be wondering if you ...

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...

Vedotin is the payload in a clutch of ADCs that Pfizer acquired in the Seagen buyout, including the approved products Adcetris, Padcev and Tivdak. Summit's stock price dropped by nearly 15% during ...